Insider trade

Alamar Biosciences (ALMR): 10% owner sold ~$25K

Qiming Corporate GP VI, 10% owner at Alamar Biosciences, sold ~$25K of Alamar Biosciences shares.

~$25K
Approx. value · 793 sh @ $31.96
1.4M
Holds after · shares reported
Traded
Oct 30, 2026
Filed
Nov 3, 2026

What stands out in this filing

  • After this sale the filing reports 1,402,275 shares, held indirectly.
  • 793 shares at an average of $31.96 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 28, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 28, 2026, the board of directors (the “Board”) of Alamar Biosciences, Inc. (the “Company”) appointed Robert Ragusa to the Board, effective as of September 1, 2026.”
  2. Sep 17, 2026Federal contract · $57K obligatedDepartment of Health and Human Services awarded Alamar Biosciences, Inc.: $57K obligated to date
  3. Sep 18, 2026Federal contract · $100K obligatedDepartment of Health and Human Services awarded Alamar Biosciences, Inc.: $100K obligated to date
  4. Sep 21, 2026Federal contract · $40K obligatedDepartment of Health and Human Services awarded Alamar Biosciences, Inc.: $40K obligated to date
  5. Oct 15, 2026Insider · 1 personInsiders: 8 sales (~$4.8M)
  6. Oct 16, 2026Insider · 1 personInsiders: 4 sales (~$4K)
  7. Oct 19, 2026Insider · 1 personInsiders: 4 sales (~$2.0M)
  8. Oct 20, 2026Insider · 1 personInsiders: 12 sales (~$4.0M)
  9. Oct 21, 2026Insider · 1 personInsiders: 12 sales (~$6.3M)
  10. Oct 22, 2026Insider · 1 personInsiders: 12 sales (~$3.9M)
  11. Oct 23, 2026Insider · 1 personInsiders: 12 sales (~$4.5M)
  12. Oct 26, 2026Insider · 1 personInsiders: 8 sales (~$4.0M)
  13. Oct 27, 2026Insider · 1 personInsiders: 5 sales (~$679K)
  14. Oct 30, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“After more than five years of exemplary service, on October 30, 2026, Timothy “Tod” White informed the Company that he will retire from his current position as President of the Company, effective as of December 31, 2026.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alamar Biosciences

For Alamar Biosciences, OQRO holds 132 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALMR page.

Other recent filings by Qiming Corporate GP VI, Ltd., 10% owner

The full history of Qiming Corporate GP VI, Ltd., 10% owner is on the profile page.

How this filing works

Explore the data

Common questions

Which Alamar Biosciences (ALMR) insider traded, and how much?

Qiming Corporate GP VI, 10% owner at Alamar Biosciences, sold ~$25K of Alamar Biosciences shares. 793 shares at $31.96.

When did it happen, and when was it made public?

Traded: Oct 30, 2026. Filed: Nov 3, 2026. That is 4 days between the two dates.

What stands out in this filing?

After this sale the filing reports 1,402,275 shares, held indirectly. 793 shares at an average of $31.96 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Alamar Biosciences recently?

For Alamar Biosciences, OQRO holds 132 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days. They are listed on the ALMR page.

Does this mean ALMR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Alamar Biosciences

Everything OQRO holds on this company is on its ALMR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data